ClinicalTrials.Veeva

Menu

Immunonutrition in Ulcerative Colitis

B

Baptist Memorial Health Care Corporation

Status

Unknown

Conditions

Ulcerative Colitis

Treatments

Dietary Supplement: Nutrition supplement
Dietary Supplement: Placebo supplement

Study type

Interventional

Funder types

Other

Identifiers

NCT03594708
UCS2018

Details and patient eligibility

About

This study tests the hypothesis that a supplement that combines a functional fiber, long chain omega-3 polyunsaturated fatty acids (PUFAs), vitamin D3, vitamin E, and zinc will reduce clinical symptoms, decrease pro-inflammatory cytokines in the blood and ergo decrease inflammation, promote beneficial microbial activity in the colon, and help recovery of the intestinal mucosa of ulcerative colitis (UC) patients compared with a placebo.

Full description

An anticipated 30 participants with newly diagnosed active ulcerative colitis will be recruited to participate in a randomized control trial, with 50% of the subjects distributed to the supplement (n=15) and the other 50% provided a placebo control (n=15). This is considered as a "proof of concept" study to determine if there is evidence that a multi-ingredient supplement (immunonutrition) will reduce UC disease severity.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with active ulcerative colitis (proof of diagnosis from gastroenterologist), over 18 years old, has over 50% gut remaining, fully connected bowels (no colostomy), currently on 5-aminosalicylates (ASA) drugs, not pregnant or lactating

Exclusion criteria

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
placebo consisting of rice starch, light olive oil, and vegetable oil
Treatment:
Dietary Supplement: Placebo supplement
Supplement
Active Comparator group
Description:
active supplement consisting of a fermentable fiber, omega-3 polyunsaturated fatty acid, vitamin D3, vitamin E, and zinc
Treatment:
Dietary Supplement: Nutrition supplement

Trial contacts and locations

1

Loading...

Central trial contact

Katie E Cook, BA; Randal K Buddington, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems